Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Shumin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-6541-2486; OpenAlex author ID A5100374594. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2022: 3 papers · 2023: 1 paper

Papers 4

  1. Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2023.216206↗
  2. Characterization of DNA damage response deficiency in pancreatic cancer patients from China. Co-author DOI 10.1002/cac2.12238↗
  3. HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53. Co-author DOI 10.1186/s12935-022-02807-4↗
  4. Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer. Co-author DOI 10.18632/aging.204031↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaofei Zhang · 4 shared papers, 2022–2023 · strength 0.55
  2. Tiebo Mao · 4 shared papers, 2022–2023 · strength 0.55
  3. Liwei Wang · 4 shared papers, 2022–2023 · strength 0.55
  4. Weiyu Ge · 3 shared papers, 2022–2023 · strength 0.44
  5. Jiujie Cui · 3 shared papers, 2022–2023 · strength 0.41
  6. Shengbai Xue · 2 shared papers, 2022–2023 · strength 0.30
  7. Jiayu Yao · 2 shared papers, 2022 · strength 0.25
  8. Ming Quan · 1 shared paper, 2023 · strength 0.16
  9. Xiao Zhang · 1 shared paper, 2022 · strength 0.15
  10. Feng Jiao · 1 shared paper, 2022 · strength 0.11
  11. Yingbin Liu · 1 shared paper, 2022 · strength 0.11
  12. Yu Wang · 1 shared paper, 2022 · strength 0.11
  13. Qiang Liu · 1 shared paper, 2022 · strength 0.11
  14. Jiong Hu · 1 shared paper, 2022 · strength 0.11
  15. Yongwei Sun · 1 shared paper, 2022 · strength 0.11
  16. Yuexiang Wang · 1 shared paper, 2022 · strength 0.11
  17. Deliang Fu · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.